Serveur d'exploration sur la rapamycine et les champignons

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Rapamycin-resistant mTORC1 kinase activity is required for herpesvirus replication.

Identifieur interne : 001400 ( Main/Exploration ); précédent : 001399; suivant : 001401

Rapamycin-resistant mTORC1 kinase activity is required for herpesvirus replication.

Auteurs : Nathaniel J. Moorman [États-Unis] ; Thomas Shenk

Source :

RBID : pubmed:20181700

Descripteurs français

English descriptors

Abstract

Human cytomegalovirus (HCMV) infection has been shown to activate the mTORC1 signaling pathway. However, the phosphorylation of mTORC1 targets is differentially sensitive to the mTORC1 inhibitor rapamycin, and the drug inhibits HCMV replication to a modest extent. Using Torin1, a newly developed inhibitor that targets the catalytic site of mTOR kinase, we show that HCMV replication requires both rapamycin-sensitive and rapamycin-resistant mTOR activity. The treatment of infected cells with Torin1 inhibits the phosphorylation of rapamycin-sensitive and rapamycin-resistant mTOR targets and markedly blocks the production of virus progeny. The blockade of mTOR signaling with Torin1, but not rapamycin, disrupts the assembly of the eIF4F complex and increases the association of the translational repressor 4EBP1 to the 7-methylguanosine cap-binding complex. Torin1 does not affect HCMV entry and only modestly reduces the accumulation of the immediate-early and early viral proteins that were tested despite the disruption of the eIF4F complex. In contrast, Torin1 significantly decreases the accumulation of viral DNA and the pUL99 viral late protein. Similar mTOR signaling events were observed during murine cytomegalovirus (MCMV) infection, and we utilized murine fibroblasts containing several different mutations to dissect the mechanism by which Torin1 inhibits MCMV replication. This approach demonstrated that mTORC2 and the Akt1 and Akt2 kinases are not required for the Torin1-mediated inhibition of cytomegalovirus replication. The inhibition of MCMV replication by Torin1 was rescued in cells lacking 4EBP1, demonstrating that the inactivation of 4EBP1 by mTORC1 is critical for cytomegalovirus replication. Finally, we show that Torin1 inhibits the replication of representative members of the alpha-, beta-, and gammaherpesvirus families, demonstrating the potential of mTOR kinase inhibitors as broad-spectrum antiviral agents.

DOI: 10.1128/JVI.02733-09
PubMed: 20181700
PubMed Central: PMC2863801


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Rapamycin-resistant mTORC1 kinase activity is required for herpesvirus replication.</title>
<author>
<name sortKey="Moorman, Nathaniel J" sort="Moorman, Nathaniel J" uniqKey="Moorman N" first="Nathaniel J" last="Moorman">Nathaniel J. Moorman</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Molecular Biology, Princeton University, Princeton, NJ 08544-1014, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Molecular Biology, Princeton University, Princeton, NJ 08544-1014</wicri:regionArea>
<placeName>
<region type="state">New Jersey</region>
<settlement type="city">Princeton (New Jersey)</settlement>
</placeName>
<orgName type="university">Université de Princeton</orgName>
</affiliation>
</author>
<author>
<name sortKey="Shenk, Thomas" sort="Shenk, Thomas" uniqKey="Shenk T" first="Thomas" last="Shenk">Thomas Shenk</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2010">2010</date>
<idno type="RBID">pubmed:20181700</idno>
<idno type="pmid">20181700</idno>
<idno type="doi">10.1128/JVI.02733-09</idno>
<idno type="pmc">PMC2863801</idno>
<idno type="wicri:Area/Main/Corpus">001430</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001430</idno>
<idno type="wicri:Area/Main/Curation">001430</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001430</idno>
<idno type="wicri:Area/Main/Exploration">001430</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Rapamycin-resistant mTORC1 kinase activity is required for herpesvirus replication.</title>
<author>
<name sortKey="Moorman, Nathaniel J" sort="Moorman, Nathaniel J" uniqKey="Moorman N" first="Nathaniel J" last="Moorman">Nathaniel J. Moorman</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Molecular Biology, Princeton University, Princeton, NJ 08544-1014, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Molecular Biology, Princeton University, Princeton, NJ 08544-1014</wicri:regionArea>
<placeName>
<region type="state">New Jersey</region>
<settlement type="city">Princeton (New Jersey)</settlement>
</placeName>
<orgName type="university">Université de Princeton</orgName>
</affiliation>
</author>
<author>
<name sortKey="Shenk, Thomas" sort="Shenk, Thomas" uniqKey="Shenk T" first="Thomas" last="Shenk">Thomas Shenk</name>
</author>
</analytic>
<series>
<title level="j">Journal of virology</title>
<idno type="eISSN">1098-5514</idno>
<imprint>
<date when="2010" type="published">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adaptor Proteins, Signal Transducing (metabolism)</term>
<term>Animals (MeSH)</term>
<term>Carrier Proteins (metabolism)</term>
<term>Cell Cycle Proteins (MeSH)</term>
<term>Cell Line (MeSH)</term>
<term>Cytomegalovirus (physiology)</term>
<term>Eukaryotic Initiation Factor-4F (antagonists & inhibitors)</term>
<term>Eukaryotic Initiation Factors (MeSH)</term>
<term>Fibroblasts (virology)</term>
<term>Humans (MeSH)</term>
<term>Intracellular Signaling Peptides and Proteins (antagonists & inhibitors)</term>
<term>Mechanistic Target of Rapamycin Complex 1 (MeSH)</term>
<term>Mice (MeSH)</term>
<term>Multiprotein Complexes (MeSH)</term>
<term>Muromegalovirus (physiology)</term>
<term>Phosphoproteins (metabolism)</term>
<term>Protein Kinase Inhibitors (pharmacology)</term>
<term>Protein-Serine-Threonine Kinases (antagonists & inhibitors)</term>
<term>Proteins (MeSH)</term>
<term>RNA, Messenger (metabolism)</term>
<term>Sirolimus (pharmacology)</term>
<term>TOR Serine-Threonine Kinases (MeSH)</term>
<term>Transcription Factors (physiology)</term>
<term>Virus Replication (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>ARN messager (métabolisme)</term>
<term>Animaux (MeSH)</term>
<term>Complexe-1 cible mécanistique de la rapamycine (MeSH)</term>
<term>Complexes multiprotéiques (MeSH)</term>
<term>Cytomegalovirus (physiologie)</term>
<term>Facteur-4F d'initiation eucaryote (antagonistes et inhibiteurs)</term>
<term>Facteurs d'initiation eucaryotes (MeSH)</term>
<term>Facteurs de transcription (physiologie)</term>
<term>Fibroblastes (virologie)</term>
<term>Humains (MeSH)</term>
<term>Inhibiteurs de protéines kinases (pharmacologie)</term>
<term>Lignée cellulaire (MeSH)</term>
<term>Muromegalovirus (physiologie)</term>
<term>Phosphoprotéines (métabolisme)</term>
<term>Protein-Serine-Threonine Kinases (antagonistes et inhibiteurs)</term>
<term>Protéines (MeSH)</term>
<term>Protéines adaptatrices de la transduction du signal (métabolisme)</term>
<term>Protéines de transport (métabolisme)</term>
<term>Protéines du cycle cellulaire (MeSH)</term>
<term>Protéines et peptides de signalisation intracellulaire (antagonistes et inhibiteurs)</term>
<term>Réplication virale (MeSH)</term>
<term>Sirolimus (pharmacologie)</term>
<term>Souris (MeSH)</term>
<term>Sérine-thréonine kinases TOR (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en">
<term>Eukaryotic Initiation Factor-4F</term>
<term>Intracellular Signaling Peptides and Proteins</term>
<term>Protein-Serine-Threonine Kinases</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Adaptor Proteins, Signal Transducing</term>
<term>Carrier Proteins</term>
<term>Phosphoproteins</term>
<term>RNA, Messenger</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Protein Kinase Inhibitors</term>
<term>Sirolimus</term>
</keywords>
<keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr">
<term>Facteur-4F d'initiation eucaryote</term>
<term>Protein-Serine-Threonine Kinases</term>
<term>Protéines et peptides de signalisation intracellulaire</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>ARN messager</term>
<term>Phosphoprotéines</term>
<term>Protéines adaptatrices de la transduction du signal</term>
<term>Protéines de transport</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Inhibiteurs de protéines kinases</term>
<term>Sirolimus</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr">
<term>Cytomegalovirus</term>
<term>Facteurs de transcription</term>
<term>Muromegalovirus</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Cytomegalovirus</term>
<term>Muromegalovirus</term>
<term>Transcription Factors</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Fibroblastes</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Fibroblasts</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Cell Cycle Proteins</term>
<term>Cell Line</term>
<term>Eukaryotic Initiation Factors</term>
<term>Humans</term>
<term>Mechanistic Target of Rapamycin Complex 1</term>
<term>Mice</term>
<term>Multiprotein Complexes</term>
<term>Proteins</term>
<term>TOR Serine-Threonine Kinases</term>
<term>Virus Replication</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Complexe-1 cible mécanistique de la rapamycine</term>
<term>Complexes multiprotéiques</term>
<term>Facteurs d'initiation eucaryotes</term>
<term>Humains</term>
<term>Lignée cellulaire</term>
<term>Protéines</term>
<term>Protéines du cycle cellulaire</term>
<term>Réplication virale</term>
<term>Souris</term>
<term>Sérine-thréonine kinases TOR</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Human cytomegalovirus (HCMV) infection has been shown to activate the mTORC1 signaling pathway. However, the phosphorylation of mTORC1 targets is differentially sensitive to the mTORC1 inhibitor rapamycin, and the drug inhibits HCMV replication to a modest extent. Using Torin1, a newly developed inhibitor that targets the catalytic site of mTOR kinase, we show that HCMV replication requires both rapamycin-sensitive and rapamycin-resistant mTOR activity. The treatment of infected cells with Torin1 inhibits the phosphorylation of rapamycin-sensitive and rapamycin-resistant mTOR targets and markedly blocks the production of virus progeny. The blockade of mTOR signaling with Torin1, but not rapamycin, disrupts the assembly of the eIF4F complex and increases the association of the translational repressor 4EBP1 to the 7-methylguanosine cap-binding complex. Torin1 does not affect HCMV entry and only modestly reduces the accumulation of the immediate-early and early viral proteins that were tested despite the disruption of the eIF4F complex. In contrast, Torin1 significantly decreases the accumulation of viral DNA and the pUL99 viral late protein. Similar mTOR signaling events were observed during murine cytomegalovirus (MCMV) infection, and we utilized murine fibroblasts containing several different mutations to dissect the mechanism by which Torin1 inhibits MCMV replication. This approach demonstrated that mTORC2 and the Akt1 and Akt2 kinases are not required for the Torin1-mediated inhibition of cytomegalovirus replication. The inhibition of MCMV replication by Torin1 was rescued in cells lacking 4EBP1, demonstrating that the inactivation of 4EBP1 by mTORC1 is critical for cytomegalovirus replication. Finally, we show that Torin1 inhibits the replication of representative members of the alpha-, beta-, and gammaherpesvirus families, demonstrating the potential of mTOR kinase inhibitors as broad-spectrum antiviral agents.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">20181700</PMID>
<DateCompleted>
<Year>2010</Year>
<Month>05</Month>
<Day>04</Day>
</DateCompleted>
<DateRevised>
<Year>2019</Year>
<Month>12</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1098-5514</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>84</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2010</Year>
<Month>May</Month>
</PubDate>
</JournalIssue>
<Title>Journal of virology</Title>
<ISOAbbreviation>J Virol</ISOAbbreviation>
</Journal>
<ArticleTitle>Rapamycin-resistant mTORC1 kinase activity is required for herpesvirus replication.</ArticleTitle>
<Pagination>
<MedlinePgn>5260-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.02733-09</ELocationID>
<Abstract>
<AbstractText>Human cytomegalovirus (HCMV) infection has been shown to activate the mTORC1 signaling pathway. However, the phosphorylation of mTORC1 targets is differentially sensitive to the mTORC1 inhibitor rapamycin, and the drug inhibits HCMV replication to a modest extent. Using Torin1, a newly developed inhibitor that targets the catalytic site of mTOR kinase, we show that HCMV replication requires both rapamycin-sensitive and rapamycin-resistant mTOR activity. The treatment of infected cells with Torin1 inhibits the phosphorylation of rapamycin-sensitive and rapamycin-resistant mTOR targets and markedly blocks the production of virus progeny. The blockade of mTOR signaling with Torin1, but not rapamycin, disrupts the assembly of the eIF4F complex and increases the association of the translational repressor 4EBP1 to the 7-methylguanosine cap-binding complex. Torin1 does not affect HCMV entry and only modestly reduces the accumulation of the immediate-early and early viral proteins that were tested despite the disruption of the eIF4F complex. In contrast, Torin1 significantly decreases the accumulation of viral DNA and the pUL99 viral late protein. Similar mTOR signaling events were observed during murine cytomegalovirus (MCMV) infection, and we utilized murine fibroblasts containing several different mutations to dissect the mechanism by which Torin1 inhibits MCMV replication. This approach demonstrated that mTORC2 and the Akt1 and Akt2 kinases are not required for the Torin1-mediated inhibition of cytomegalovirus replication. The inhibition of MCMV replication by Torin1 was rescued in cells lacking 4EBP1, demonstrating that the inactivation of 4EBP1 by mTORC1 is critical for cytomegalovirus replication. Finally, we show that Torin1 inhibits the replication of representative members of the alpha-, beta-, and gammaherpesvirus families, demonstrating the potential of mTOR kinase inhibitors as broad-spectrum antiviral agents.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Moorman</LastName>
<ForeName>Nathaniel J</ForeName>
<Initials>NJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Molecular Biology, Princeton University, Princeton, NJ 08544-1014, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shenk</LastName>
<ForeName>Thomas</ForeName>
<Initials>T</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 CA085786</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>CA85786</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2010</Year>
<Month>02</Month>
<Day>24</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Virol</MedlineTA>
<NlmUniqueID>0113724</NlmUniqueID>
<ISSNLinking>0022-538X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D048868">Adaptor Proteins, Signal Transducing</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D002352">Carrier Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018797">Cell Cycle Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C087000">EIF4EBP1 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C499527">Eif4ebp1 protein, mouse</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D039562">Eukaryotic Initiation Factor-4F</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D039642">Eukaryotic Initiation Factors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D047908">Intracellular Signaling Peptides and Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D046912">Multiprotein Complexes</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010750">Phosphoproteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D047428">Protein Kinase Inhibitors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011506">Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.1.1</RegistryNumber>
<NameOfSubstance UI="C546842">MTOR protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.1.1</RegistryNumber>
<NameOfSubstance UI="D058570">TOR Serine-Threonine Kinases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.1.1</RegistryNumber>
<NameOfSubstance UI="C546843">mTOR protein, mouse</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.1</RegistryNumber>
<NameOfSubstance UI="D000076222">Mechanistic Target of Rapamycin Complex 1</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 2.7.11.1</RegistryNumber>
<NameOfSubstance UI="D017346">Protein-Serine-Threonine Kinases</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>W36ZG6FT64</RegistryNumber>
<NameOfSubstance UI="D020123">Sirolimus</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D048868" MajorTopicYN="N">Adaptor Proteins, Signal Transducing</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002352" MajorTopicYN="N">Carrier Proteins</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018797" MajorTopicYN="N">Cell Cycle Proteins</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003587" MajorTopicYN="N">Cytomegalovirus</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D039562" MajorTopicYN="N">Eukaryotic Initiation Factor-4F</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="N">antagonists & inhibitors</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D039642" MajorTopicYN="N">Eukaryotic Initiation Factors</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005347" MajorTopicYN="N">Fibroblasts</DescriptorName>
<QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D047908" MajorTopicYN="N">Intracellular Signaling Peptides and Proteins</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="N">antagonists & inhibitors</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000076222" MajorTopicYN="N">Mechanistic Target of Rapamycin Complex 1</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D046912" MajorTopicYN="N">Multiprotein Complexes</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018146" MajorTopicYN="N">Muromegalovirus</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D010750" MajorTopicYN="N">Phosphoproteins</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D047428" MajorTopicYN="N">Protein Kinase Inhibitors</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017346" MajorTopicYN="N">Protein-Serine-Threonine Kinases</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="N">antagonists & inhibitors</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011506" MajorTopicYN="N">Proteins</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D020123" MajorTopicYN="N">Sirolimus</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058570" MajorTopicYN="N">TOR Serine-Threonine Kinases</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014779" MajorTopicYN="Y">Virus Replication</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2010</Year>
<Month>2</Month>
<Day>26</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2010</Year>
<Month>2</Month>
<Day>26</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2010</Year>
<Month>5</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">20181700</ArticleId>
<ArticleId IdType="pii">JVI.02733-09</ArticleId>
<ArticleId IdType="doi">10.1128/JVI.02733-09</ArticleId>
<ArticleId IdType="pmc">PMC2863801</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Cell. 2002 Jul 26;110(2):163-75</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12150925</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Cell Biol. 2002 Sep;4(9):648-57</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12172553</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2002 Nov;76(21):11054-64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12368348</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13571-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12271141</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Biochem. 2002 Nov;269(22):5338-49</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12423332</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2003 Jan;77(1):228-36</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12477828</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Opin Struct Biol. 2003 Feb;13(1):56-63</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12581660</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trends Biochem Sci. 2003 Mar;28(3):130-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12633992</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Genes Dev. 2003 Jun 1;17(11):1352-65</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12782654</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2003 Oct;77(19):10594-605</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12970444</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Top Microbiol Immunol. 2004;279:169-97</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14560958</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int Rev Immunol. 2004 Jan-Apr;23(1-2):199-220</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14690861</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Genes Dev. 2004 Mar 15;18(6):660-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15075293</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2004 Oct;78(20):11030-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15452223</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1973 Aug;12(2):209-17</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">4355928</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Protein Chem. 1991 Apr;10(2):151-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1718307</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1992 May;66(5):3241-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1313929</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Dev Cell. 2006 Dec;11(6):859-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17141160</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2007 Apr;81(7):3109-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17202209</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Blood. 2007 Jul 15;110(2):490-500</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17392502</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Transplantation. 2007 Dec 15;84(11):1436-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18091519</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Microbiol. 2008 Apr;6(4):266-75</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18311165</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Host Microbe. 2008 Apr 17;3(4):253-62</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18407068</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1432-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9465032</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1998 Sep;72(9):7005-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9696792</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>FEBS Lett. 1998 Sep 11;435(1):105-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9755868</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1999 Aug;73(8):7056-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10400809</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2004 Nov 23;101(47):16642-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15536129</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2005 Feb 3;433(7025):477-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15690031</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2005 May;79(9):5499-506</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15827164</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Res. 2005 Apr 15;65(8):3336-46</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15833867</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2005 Jul;79(13):8057-64</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15956551</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Genes Dev. 2006 Feb 15;20(4):461-72</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16481474</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virus Res. 2006 Jul;119(1):89-99</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16305812</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14182-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16959881</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Dev Cell. 2006 Oct;11(4):583-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16962829</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oncogene. 2006 Oct 16;25(48):6384-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17041624</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2006 Dec;80(23):11817-26</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16987971</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Res. 2008 Jun 15;68(12):4640-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18559509</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Top Microbiol Immunol. 2008;325:263-79</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18637511</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2008 Oct;82(19):9525-36</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18653451</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cancer Res. 2008 Oct 15;68(20):8361-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18922908</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2009 Mar 20;284(12):8023-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19150980</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Pathog. 2009 Mar;5(3):e1000334</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19300492</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2009 May 29;137(5):873-86</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19446321</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Cycle. 2009 Dec;8(23):3831-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19901542</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Exp Cell Res. 1999 Nov 25;253(1):100-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10579915</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Microbiol Mol Biol Rev. 2000 Jun;64(2):239-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10839817</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Annu Rev Biochem. 1999;68:913-63</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10872469</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2000 Dec;74(23):11215-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11070019</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2001 Jul;75(13):6022-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11390604</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Med. 2001 Oct;7(10):1128-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11590436</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 1994 Sep 16;269(37):23185-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8083223</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1995 Dec;69(12):7960-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7494309</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 1996 Jul 12;273(5272):239-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8662507</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1997 Aug;71(8):5894-904</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9223479</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>New Jersey</li>
</region>
<settlement>
<li>Princeton (New Jersey)</li>
</settlement>
<orgName>
<li>Université de Princeton</li>
</orgName>
</list>
<tree>
<noCountry>
<name sortKey="Shenk, Thomas" sort="Shenk, Thomas" uniqKey="Shenk T" first="Thomas" last="Shenk">Thomas Shenk</name>
</noCountry>
<country name="États-Unis">
<region name="New Jersey">
<name sortKey="Moorman, Nathaniel J" sort="Moorman, Nathaniel J" uniqKey="Moorman N" first="Nathaniel J" last="Moorman">Nathaniel J. Moorman</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001400 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001400 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    RapamycinFungusV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:20181700
   |texte=   Rapamycin-resistant mTORC1 kinase activity is required for herpesvirus replication.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:20181700" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a RapamycinFungusV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Thu Nov 19 21:55:41 2020. Site generation: Thu Nov 19 22:00:39 2020